Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'haemophilia' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 355 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Minhas, HL; Giangrande, PLF
      Presentation of severe haemophilia - A role for accident and emergency doctors?

      EMERGENCY MEDICINE JOURNAL
    2. Liras, A
      Gene therapy for haemophilia: the end of a 'royal pathology' in the third millennium?

      HAEMOPHILIA
    3. Wallny, T; Hess, L; Seuser, A; Zander, D; Brackmann, HH; Kraft, CN
      Pain status of patients with severe haemophilic arthropathy

      HAEMOPHILIA
    4. Miners, AH; Sabin, CA; Tolley, KH; Parnaby, A; Lee, CA
      Assessing the relationship between productivity levels and severity of haemophilia

      HAEMOPHILIA
    5. Jijina, F; Ghosh, K; Madkaikar, M; Mohanty, D
      Ophthalmic surgery in haemophilia

      HAEMOPHILIA
    6. Sonbol, H; Pelargidou, M; Lucas, VS; Gelbier, MJ; Mason, C; Roberts, GJ
      Dental health indices and caries-related microflora in children with severe haemophilia

      HAEMOPHILIA
    7. Timur, AA; Gurgey, A; Aktuglu, G; Kavakli, K; Canatan, D; Olek, K; Caglayan, SH
      Molecular pathology of haemophilia A in Turkish patients: identification of 36 independent mutations

      HAEMOPHILIA
    8. Kavakli, K; Huseyinov, A; Coker, I; Aydinok, Y; Nisli, G
      Intraleucocyte platelet-activating factor levels in desmopressin-treated patients with haemophilia A and von Willebrand disease

      HAEMOPHILIA
    9. Hodge, G; Han, P
      Factor VIII concentrate inhibits T helper type 2 cytokine production in vitro: relevance to inhibitor antibody formation

      HAEMOPHILIA
    10. Gilchrist, GS; Wilke, JL; Muehlenbein, LR; Danilenko-Dixon, D
      Intrauterine correction of factor VIII (FVIII) deficiency

      HAEMOPHILIA
    11. Hothi, DK; Kelsall, W; Baglin, T; Williams, DM
      Bacterial endocarditis in a child with haemophilia B: risks of central venous catheters

      HAEMOPHILIA
    12. Vianello, F; Belvini, D; Dal Bello, F; Tagariello, G; Zanon, E; Lombardi, AM; Zerbinati, P; Girolami, A
      Mild bleeding diathesis in a boy with combined severe haemophilia B (C-10400 -> T) and heterozygous factor V Leiden

      HAEMOPHILIA
    13. Ghosh, K; Shetty, S; Mohanty, D
      Haemorrhage in upper cervical cord: an unusual manifestation in moderate haemophilia patients who ride motorbikes

      HAEMOPHILIA
    14. Cooper, HA; Jones, CP; Campion, E; Roberts, HR; Hedner, U
      Rationale for the use of high dose rFVIIa in a high-titre inhibitor patient with haemophilia B during major orthopaedic procedures

      HAEMOPHILIA
    15. Meiklejohn, DJ; Watson, HG
      Acquired haemophilia in association with organ-specific autoimmune disease

      HAEMOPHILIA
    16. Regina, S; Colombat, P; Fimbel, B; Guerois, C; Gruel, Y
      Acquired inhibitor to factor VIII in a patient with Hodgkin's disease following treatment with interferon-alpha

      HAEMOPHILIA
    17. Gassel, F; Kraft, CN; Wallny, T; Hess, L; Schmitt, O
      Soft-tissue angioleiomyoma of the hand as a rare differential diagnosis ofhaemophilic pseudotumour

      HAEMOPHILIA
    18. Scharrer, I; Ehrlich, HJ
      Lack of evidence for increased inhibitor incidence in patients switched from plasma-derived to recombinant factor VIII

      HAEMOPHILIA
    19. Berntorp, E; Petrini, P; Dockter, G; Tengborn, L; Wendisch, I; Eberl, W; Aumann, V; Frade, G; Seliger, I; Engl, W; Ehrlich, H
      An approach to study the viral safety of plasma-derived products in previously treated, non-infected patients

      HAEMOPHILIA
    20. Mauser-Bunschoten, EP; van der Bom, JG; Bongers, M; Twijnstra, M; Roosendaal, G; Fischer, K; van den Berg, HM
      Purity of factor VIII product and incidence of inhibitors in previously untreated patients with haemophilia A

      HAEMOPHILIA
    21. Gensana, M; Altisent, C; Aznar, JA; Casana, P; Hernandez, F; Jorquera, JI; Magallon, M; Massot, M; Puig, L
      Influence of von Willebrand factor on the reactivity of human factor VIII inhibitors with factor VIII

      HAEMOPHILIA
    22. Kallas, A; Talpsep, T
      von Willebrand factor in factor VIII concentrates protects against neutralization by factor VIII antibodies of haemophilia A patients

      HAEMOPHILIA
    23. Theophilus, BDM; Enayat, MS; Williams, MD; Hill, FGH
      Site and type of mutations in the factor VIII gene in patients and carriers of haemophilia A

      HAEMOPHILIA
    24. Hacker, MR; Geraghty, S; Manco-Johnson, M
      Barriers to compliance with prophylaxis therapy in haemophilia

      HAEMOPHILIA
    25. Mauser-Bunschoten, EP; Hamers, MJ; De Roode, D; Terlingen-Van Baaren, G; De Kleijn, P; Bos, R; van den Berg, HM
      Improvement of patient education and information: development of a patient's information dossier

      HAEMOPHILIA
    26. Acquila, M; Bottini, F; Valetto, A; Caprino, D; Mori, PG; Bicocchi, MP
      A new strategy for prenatal diagnosis in a sporadic haemophilia B family

      HAEMOPHILIA
    27. Bauduer, F; Ducout, L; Bendriss, P; Falaises, B; Lavergne, JM
      Mild haemophilia A discovered in a previously multi-operated 73-year-old man: characterization of a new mutation

      HAEMOPHILIA
    28. Godreuil, S; Navarro, R; Quittet, P; Landreau, L; Schved, JF; Biron-Andreani, C
      Acquired haemophilia in the elderly is a severe disease: report of five new cases

      HAEMOPHILIA
    29. Yoshioka, A; Shima, M; Fukutake, K; Takamatsu, J; Shirahata, A
      Safety and efficacy of a new recombinant FVIII formulated with sucrose (rFVIII-FS) in patients with haemophilia A: a long-term, multicentre clinical study in Japan

      HAEMOPHILIA
    30. Leissinger, C; Becton, D; Cornell, C; Gill, JC
      High-dose DDAVP intranasal spray (Stimate((R))) for the prevention and treatment of bleeding in patients with mild haemophilia A, mild or moderate type 1 von Willebrand disease and symptomatic carriers of haemophilia A

      HAEMOPHILIA
    31. Astermark, J; Berntorp, E; White, GC; Kroner, BL
      The Malmo International Brother Study (MIBS): further support for genetic predisposition to inhibitor development

      HAEMOPHILIA
    32. Ghosh, K; Shetty, S; Kulkarni, B; Nair, S; Pawar, A; Khare, A; Baindur, S; Mohanty, D
      Development of inhibitors in patients with haemophilia from India

      HAEMOPHILIA
    33. Ekert, H; Brewin, T; Boey, W; Davey, P; Tilden, D
      Cost-utility analysis of recombinant factor VIIa (NovoSeven((R))) in six children with long-standing inhibitors to factor VIII or IX

      HAEMOPHILIA
    34. Klukowska, A; Czyrny, Z; Laguna, P; Brzewski, M; Serafin-Krol, MA; Rokicka-Milewska, R
      Correlation between clinical, radiological and ultrasonographical image ofknee joints in children with haemophilia

      HAEMOPHILIA
    35. Schoenmakers, MAGC; Gulmans, VAM; Helders, PJM; Van den Berg, HM
      Motor performance and disability in Dutch children with haemophilia: a comparison with their healthy peers

      HAEMOPHILIA
    36. Soares, RPS; Chamone, DAF; Bydlowski, SP
      Factor VIII gene inversions and polymorphisms in Brazilian patients with haemophilia A: carrier detection and prenatal diagnosis

      HAEMOPHILIA
    37. Klein, I; Andrikovics, H; Bors, A; Nemes, L; Tordai, A; Varadi, A
      A haemophilia A and B molecular genetic diagnostic programme in Hungary: ahighly informative and cost-effective strategy

      HAEMOPHILIA
    38. Faradji, A; Bonnomet, F; Lecocq, J; Grunebaum, L; Desprez, D; Kern, O; Barbier, L; Sibilia, J
      Knee joint arthroplasty in a patient with haemophilia A and high inhibitortitre using recombinant factor VIIa (NovoSeven((R))): a new case report and review of the literature

      HAEMOPHILIA
    39. Kashyap, R; Choudhry, VP; Mahapatra, M; Chumber, S; Saxena, R; Kaul, HL
      Postpartum acquired haemophilia: clinical recognition and management

      HAEMOPHILIA
    40. Samaiya, A; Gupta, S; Chumber, S; Kashyap, R; Dewanda, NK; Vashisht, S; Choudhry, VP
      Blunt abdominal trauma with delayed rupture of splenic haematoma in a haemophiliac patient

      HAEMOPHILIA
    41. Yenchitsomanus, P; Thanootarakul, P; Akkarapatumwong, V; Oranwiroon, S; Pung-Amritt, P; Veerakul, G; Mahasandana, C
      Mutation causing exon 15 skipping and partial exon 16 deletion in factor VIII transcript, and a method for direct mutation detection

      HAEMOPHILIA
    42. Bjorkman, S; Shapiro, AD; Berntorp, E
      Pharmacokinetics of recombinant factor IX in relation to age of the patient: implications for dosing in prophylaxis

      HAEMOPHILIA
    43. Chowdary, P; Dasani, H; Jones, JAH; Loran, CM; Eldridge, A; Hughes, S; Collins, PW
      Recombinant factor IX (BeneFix (R)) by adjusted continuous infusion: a study of stability, sterility and clinical experience

      HAEMOPHILIA
    44. Philipp, CS
      Viral safety of a pasteurized, monoclonal antibody-purified factor VIII concentrate in previously untreated haemophilia A patients

      HAEMOPHILIA
    45. Haya, S; Lopez, MF; Aznar, JA; Batlle, J
      Immune tolerance treatment in haemophilia patients with inhibitors: the Spanish Registry

      HAEMOPHILIA
    46. Dykes, AC; Walker, ID; Lowe, GDO; Tait, RC
      Combined prednisolone and intravenous immunoglobulin treatment for acquired factor VIII inhibitors: a 2-year review

      HAEMOPHILIA
    47. Grunewald, M; Beneke, H; Guthner, C; Germowitz, A; Brommer, A; Griesshammer, M
      Acquired haemophilia: experiences with a standardized approach

      HAEMOPHILIA
    48. De Joode, EVP; Van Meeteren, NLU; Van den Berg, HM; De Kleijn, P; Helders, PJM
      Validity of health status measurement with the Dutch Arthritis Impact Measurement Scale 2 in individuals with severe haemophilia

      HAEMOPHILIA
    49. Soucie, JM; Symons, J; Evatt, B; Brettler, D; Huszti, H; Linden, J
      Home-based factor infusion therapy and hospitalization for bleeding complications among males with haemophilia

      HAEMOPHILIA
    50. Hortelano, G; Wang, L; Xu, N; Ofosu, FA
      Sustained and therapeutic delivery of factor IX in nude haemophilia B miceby encapsulated C2C12 myoblasts: concurrent tumourigenesis

      HAEMOPHILIA
    51. Puetz, JJ; Bouhasin, JD
      High-titre factor VIII inhibitor in two children with mild haemophilia A

      HAEMOPHILIA
    52. Aydogdu, S; Memis, A; Kavakli, K; Balkan, C
      The pelvi-femoral incomplete bone bridge in a patient with mild haemophilia

      HAEMOPHILIA
    53. Sheth, S; DiMichele, D; Lee, M; Lamour, J; Quaegebeur, J; Hsu, D; Addonizio, L; Piomelli, S
      Heart transplant in a factor VIII-deficient patient with a high-titre inhibitor: perioperative management using high-dose continuous infusion factor VIII and recombinant factor VIIa

      HAEMOPHILIA
    54. Aguilar, C; Lucia, JF; Simon, MA
      An emerging role for interferon in haemophiliacs with chronic hepatitis C?

      HAEMOPHILIA
    55. Ghosh, K; Shetty, S; Mohanty, D
      Milder clinical presentation of haemophilia A with severe deficiency of factor VIII as measured by one-stage assay

      HAEMOPHILIA
    56. Mondorf, W; Klinge, J; Luban, NLC; Bray, G; Saenko, E; Scandella, D
      Low factor VIII recovery in haemophilia A patients without inhibitor titreis not due to the presence of anti-factor VIII antibodies undetectable by the Bethesda assay

      HAEMOPHILIA
    57. Oranwiroon, S; Akkarapatumwong, V; Pung-Amritt, P; Treesucon, A; Veerakul, G; Mahasandana, C; Panyim, S; Yenchitsomanus, P
      Determination of haemophilia A carrier status by mutation analysis

      HAEMOPHILIA
    58. Klinge, J; Auerswald, G; Budde, U; Klose, H; Kreuz, W; Lenk, H; Scandella, D
      Detection of all anti-factor VIII antibodies in haemophilia A patients by the Bethesda assay and a more sensitive immunoprecipitation assay

      HAEMOPHILIA
    59. Rocino, A; Papa, ML; Salerno, E; Capasso, F; Miraglia, E; De Biasi, R
      Immune tolerance induction in haemophilia A patients with high-responding inhibitors to factor VIII: experience at a single institution

      HAEMOPHILIA
    60. Cid, AR; Lorenzo, JI; Haya, S; Montoro, JM; Casana, P; Aznar, JA
      A comparison of FVII : C and FVIIa assays for the monitoring of recombinant factor VIIa treatment

      HAEMOPHILIA
    61. Ebeling, F; Rasi, V; Laitinen, H; Krusius, T
      Viral markers and use of factor products among Finnish patients with bleeding disorders

      HAEMOPHILIA
    62. Katsarou, O; Terpos, E; Patsouris, E; Peristeris, E; Viniou, N; Kapsimali, V; Karafoulidou, A
      Myelodysplastic features in patients with long-term HIV infection and haemophilia

      HAEMOPHILIA
    63. Solovieva, S
      Clinical severity of disease, functional disability and health-related quality of life. Three-year follow-up study of 150 Finnish patients with coagulation disorders

      HAEMOPHILIA
    64. Parish, KL; Cotton, D; Huszti, HC; Parsons, JT
      Safer sex decision-making among men with haemophilia and HIV and their female partners

      HAEMOPHILIA
    65. Calvez, T; Biou, M; Costagliola, D; Jullien, AM; Laurian, Y; Rossi, F; Rothschild, C; Sie, P
      The French haemophilia cohort: rationale and organization of a long-term national pharmacosurveillance system

      HAEMOPHILIA
    66. Mauser-Bunschoten, EP; Roosendaal, G; Van den Berg, HM
      Product choice and haemophilia treatment in the Netherlands

      HAEMOPHILIA
    67. Petrini, P
      What factors should influence the dosage and interval of prophylactic treatment in patients with severe haemophilia A and B?

      HAEMOPHILIA
    68. Berntorp, E
      Immune tolerance induction: recombinant vs. human-derived product

      HAEMOPHILIA
    69. Srivastava, A
      Choice of factor concentrates for haemophilia: a developing world perspective

      HAEMOPHILIA
    70. Ishiguro, N; Takagi, H; Ito, T; Oguchi, T; Takamatsu, J; Iwata, H
      Rapidly destructive arthropathy of the hip in haemophilia

      HAEMOPHILIA
    71. Gilbert, MS; Cornwall, R
      The history of synoviorthesis in haemophilia

      HAEMOPHILIA
    72. Rodriguez-Merchan, EC; Wiedel, JD
      General principles and indications of synoviorthesis (medical synovectomy)in haemophilia

      HAEMOPHILIA
    73. Rodriguez-Merchan, EC; Goddard, NJ
      The technique of synoviorthesis

      HAEMOPHILIA
    74. Ayral, X
      Chemical synoviorthesis with osmic acid in haemophilia

      HAEMOPHILIA
    75. Caviglia, HA; Fernandez-Palazzi, F; Galatro, G; Perez-Bianco, R
      Chemical synoviorthesis with rifampicin in haemophilia

      HAEMOPHILIA
    76. Petersson, CJ
      Synoviorthesis with radioactive gold in haemophilia

      HAEMOPHILIA
    77. Rodriguez-Merchan, EC; Jimenez-Yuste, V; Villar, A; Quintana, M; Lopez-Cabarcos, C; Hernandez-Navarro, F
      Yttrium-90 synoviorthesis for chronic haemophilic synovitis: Madrid experience

      HAEMOPHILIA
    78. Heim, M; Goshen, E; Amit, Y; Martinowitz, U
      Synoviorthesis with radioactive Yttrium in haemophilia: Israel experience

      HAEMOPHILIA
    79. Silva, M; Luck, JV; Siegel, ME
      P-32 chromic phosphate radio synovectomy for chronic haemophilic synovitis

      HAEMOPHILIA
    80. Fernandez-Palazzi, F; Caviglia, H
      On the safety of synoviorthesis in haemophilia

      HAEMOPHILIA
    81. Querol, F; Rodriguez-Merchan, EC; Aznar, JA; Lopez-Cabarcos, C; Villar, A
      Post-synoviorthesis rehabilitation in haemophilia

      HAEMOPHILIA
    82. Aledort, LM
      Making a therapeutic choice: human versus recombinant fractions - can we do it?

      HAEMOPHILIA
    83. Hoots, WK
      The future of plasma-derived clotting factor concentrates

      HAEMOPHILIA
    84. High, KA
      Gene therapy: a 2001 perspective

      HAEMOPHILIA
    85. Biron-Andreani, C; Dupeyron, G; Mainemer, M; Schved, JF
      Successful use of recombinant factor VIIa in a haemophiliac with inhibitorundergoing cataract surgery

      BLOOD COAGULATION & FIBRINOLYSIS
    86. Beurton, I; Bertrand, MA; Bresson-Hadni, S; Parquet-Gernez, A; Goudemand, J; Paris, JC; Cales, P; Briquel, ME; Gaucher, P; Cortey, ML; Trepo, C; Miguet, JP; Cahn, JY
      Interferon alpha therapy in haemophilic patients with chronic hepatitis C:a French multicentre pilot study of 58 patients

      EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
    87. Hollmig, KA; Beck, SB; Doll, DC
      Severe bleeding complications in HIV-positive haemophiliac patients treated with protease inhibitors

      EUROPEAN JOURNAL OF MEDICAL RESEARCH
    88. Balabaud-Pichon, V; Freys, G; Faradji, A; Wolf, P; Pottecher, T
      Liver transplantation in a patient with haemophilia A and end stage liver failure

      ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION
    89. Mosnier, LO; Lisman, T; van den Berg, HM; Nieuwenhuis, HK; Meijers, JCM; Bouma, BN
      The defective down regulation of fibrinolysis in haemophilia A can be restored by increasing the TAFI plasma concentration

      THROMBOSIS AND HAEMOSTASIS
    90. Lutze, G; Aumann, V; Lutze, G; Mittler, U
      Factor VIII inhibitors in patients suffering from severe haemophilla A: problems of "very low" responders

      KLINISCHE PADIATRIE
    91. Levesque, H; Borg, JY; Bossi, P; Goudemand, J; Guillet, B; Cabane, J
      Acquired haemophilia: diagnosis and therapeutic management.

      REVUE DE MEDECINE INTERNE
    92. Santavirta, N; Solovieva, S; Helkama, O; Lehto, S; Konttinen, YT; Santavirta, S
      Musculoskeletal pain and functional ability in haemophilia A and B. Physiotherapy and rehabilitation in haemophilia patients

      RHEUMATOLOGY INTERNATIONAL
    93. Shetty, S; Ghosh, K; Parekh, S; Mohanty, D
      Combined factor VIII and IX deficiency in a family

      CLINICAL AND LABORATORY HAEMATOLOGY
    94. Saenko, E; Josic, D; Stadler, M; Sarafanov, A; Lim, YP; Shima, M; Ananyeva, N; Schwinn, H
      Molecular modifications in factor VIII concentrates produced from different plasma pools

      THROMBOSIS RESEARCH
    95. Stubbs, M; Lloyd, J
      A protocol for the dental management of von Willebrand's disease, haemophilia A and haemophilia B

      AUSTRALIAN DENTAL JOURNAL
    96. Hodge, G; Han, P
      Effect of intermediate-purity factor VIII (FVIII) concentrate on lymphocyte proliferation and apoptosis: transforming growth factor-beta is a significant immunomodulatory component of FVIII

      BRITISH JOURNAL OF HAEMATOLOGY
    97. Guillet, B; Kriaa, F; Huysse, MG; Proulle, V; George, C; Tchernia, G; D'Oiron, R; Laurian, Y; Charpentier, B; Lambert, T; Dreyfus, M
      Protein A sepharose immunoadsorption: immunological and haemostatic effects in two cases of acquired haemophilia

      BRITISH JOURNAL OF HAEMATOLOGY
    98. Ling, M; Duncan, EM; Rodgers, SE; Somogyi, AA; Crabb, GA; Street, AM; Lloyd, JV
      Classification of the kinetics of factor VIII inhibitors in haemophilia A:plasma dilution studies are more discriminatory than time-course studies

      BRITISH JOURNAL OF HAEMATOLOGY
    99. Kavakli, K; Aydinok, Y; Karapinar, D; Balkan, C
      DDAVP treatment in children with haemophilia B

      BRITISH JOURNAL OF HAEMATOLOGY
    100. Huang, CC; Shen, MC; Chen, JY; Hung, MH; Hsu, TC; Lin, SW
      Epitope mapping of factor VIII inhibitor antibodies of Chinese origin

      BRITISH JOURNAL OF HAEMATOLOGY


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 08/08/20 alle ore 15:17:57